Related Experiment Videos
Effects of different antihypertensive drugs on left ventricular function
1Division of Cardiology, Italian Hospital, Buenos Aires.
Insights
Left ventricular hypertrophy (LVH) is a heart condition often linked to hypertension. Reducing LVH is a key goal in treating high blood pressure to prevent serious cardiac issues.
Area of Science:
- Cardiology
- Hypertension Research
- Cardiac Physiology
Background:
- Left ventricular hypertrophy (LVH) is a cardiac response to hemodynamic overload, commonly seen in hypertension due to increased systemic resistance.
- While initially compensatory, LVH can lead to impaired cardiac function, reduced coronary reserve, and increased risks of angina, heart failure, arrhythmias, and sudden death.
Purpose of the Study:
- To highlight the detrimental effects of LVH in arterial hypertension.
- To emphasize the importance of LVH regression as a therapeutic goal in antihypertensive treatment.
Main Methods:
- The abstract discusses the physiological consequences of LVH.
- It reviews the impact of LVH on cardiac function and patient outcomes.
- It mentions various drug classes used in antihypertensive therapy and their effect on LVH.
Main Results:
- LVH negatively impacts both systolic and diastolic ventricular function.
- LVH is associated with reduced coronary reserve, increased incidence of angina and heart failure.
- LVH increases the risk of ventricular arrhythmias and sudden cardiac death.
Conclusions:
- Reducing LVH should be a primary objective in managing hypertension.
- Several antihypertensive drug classes, including antisympathetic agents, beta-blockers, calcium antagonists, and ACE inhibitors, show efficacy in regressing LVH.
Abstract:
Left ventricular hypertrophy (LVH) is a response by the heart to haemodynamic overload. It is frequently observed in hypertension as a consequence of work overload secondary to an increased systemic resistance. This increase is not the only cause of LVH; there are other factors which can have a significant effect on its incidence. LVH in arterial hypertension acts initially as a useful compensatory mechanism against increased peripheral resistance. However after a certain amount of time it produces changes of variable intensity which have important consequences for the heart and some of them impair cardiac performance: 1. It affects both systolic and diastolic ventricular function; 2. It reduces coronary reserve; 3. It increases the incidence of angina and heart failure; 4. It increases the incidence of ventricular arrhythmias and sudden death. It therefore seems reasonable to include the reduction of LVH among the basic aims of antihypertensive treatment. Antisympathetic drugs (methyldopa, prazosin, urapidil), adrenergic beta-blockers, calcium antagonists and the converting enzyme inhibitors have proven to have a variable degree of efficacy in effecting a regression of LVH.